Pregnane-based steroids are novel positive NMDA receptor modulators that may compensate for the effect of loss-of-function disease-associated GRIN mutations

Kysilov, B., Hrčka Krausová, B., Vyklický, V., Smejkalová, T., Kořínek, M., Horák, M., Chodounská, H., Kudová, E., Černý, J., Vyklický ml., L. Pregnane-based steroids are novel positive NMDA receptor modulators that may compensate for the effect of loss-of-function disease-associated GRIN mutations. British Journal of Pharmacology. 2022, 179(15), 3970-3990. ISSN 0007-1188. E-ISSN 1476-5381. Dostupné z: doi: 10.1111/bph.15841.